Transcripta Bio
2 known investors
Transcripta Bio uses transcriptomic data — patient-derived tissue profiled with scRNA-seq and compounds profiled with DRUG-seq — together with machine-learning models to identify drug candidates that reverse disease signatures. It focuses on neurodevelopmental, neurodegenerative, and rare muscular diseases, partnering with pharma, biotech, and academic teams.
AI & Machine LearningBiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Transcripta Bio do?
- Transcripta Bio uses transcriptomic data — patient-derived tissue profiled with scRNA-seq and compounds profiled with DRUG-seq — together with machine-learning models to identify drug candidates that reverse disease signatures. It focuses on neurodevelopmental, neurodegenerative, and rare muscular diseases, partnering with pharma, biotech, and academic teams.
- Who are Transcripta Bio's investors?
- Transcripta Bio's investors include BlueYard Capital, JAZZ Venture Partners.